Clinical Trials Browser

Withdrawn × Chemotherapy, Adjuvant × Dermatologic × Clear all

NCT00085579 2012-12-12

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Withdrawn

Melanoma